ALT ▲ +1.0% - Altimmune, Inc.
$ALT - Altimmune Announces Publication of IMPACT Phase 2b 48-Week Data in MASH in The Lancet Gastroenterology & Hepatology
12-NOV-2026 07:15 AM ET
Share this post
More filings for $ALT
ALT ▼ -0.5% - Altimmune, Inc.Nov 12, 2026ALT - Altimmune, Inc. - SEC Filing Update (10-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 10, 2026ALT ▲ +2.9% - Altimmune, Inc.Nov 9, 2026ALT ▼ -1.9% - Altimmune, Inc.Nov 5, 2026ALT ▲ +1.4% - Altimmune, Inc.Oct 19, 2026ALT ▼ -0.3% - Altimmune, Inc.Sep 23, 2026
View full $ALT filing history →💬 Comments
Loading comments…
Leave a comment